SUMMARY Twins and a singleton were born at 30 weeks' gestation although naproxen (d-2 (6'methoxy-2-naphthyl) propionic acid) had been given to the mothers in an attempt to delay parturition. Inhibition of prostaglandin synthesis was shown by very low plasma concentrations of prostaglandin E and the ductus arteriosus remained closed despite signs of pulmonary hypertension with severe hypoxaemia. Abnormalities in blood clotting, renal function, and bilirubin metabolism were also found and one infant died. Further studies of the benefits and risks of the inhibition of prostaglandin synthesis are required before this treatment ofpreterm labour is accepted.
Indomethacin and salicylates are prostaglandin synthetase inhibitors (PGSI), which suppress uterine activity in animals and humans (Wigvist et al., 1975) . Some workers have used PGSI to treat women after the onset of preterm labour (Zuckerman et al., 1974) , but experiments in lambs (Heymann and Rudolph, 1976; Levin et al., 1979) show that these drugs cross the placenta and cause great changes in the fetal circulation with closure of the ductus arteriosus and an increase in pulmonary arterial pressure. Postnatal persistent pulmonary hypertension has been described after maternal treatment with indomethacin and salicylates (Manchester et al., 1976 : Csaba et al., 1978 Levin et al., 1978) . We report 3 premature infants with this syndrome who were born to mothers who had been given naproxen (d-2 (6'methoxy-2-naphthyl) propionic acid) which is another potent PGSI.
Case 1 A girl weighing 1 28 kg was born at 30 weeks' gestation to a 28-year-old mother. There had been recurrent vaginal bleeding throughout pregnancy and at 28 weeks uterine contractions became frequent. Naproxen 250 mg was given orally 8-hourly for 6 days and contractions became less frequent but 48 hours after stopping naproxen spontaneous labour recurred. The baby was delivered by caesarean section because of breech presentation. The Apgar score was 2 and the baby was resuscitated with oxygen and positive pressure ventilation, but cyanosis persisted and tachypnoea developed. Artificial ventilation was continued and at 40 minutes while breathing 50 % oxygen arterial pH was 7 04, Pao2 3 0 kPa (23 mmHg), and Paco2 7 9 kPa (59 mmHg). Breath sounds were normal and no heart murmurs were heard. The haematocrit was 52 % and blood glucose concentration normal. Parenchymal and vascular markings and the heart size were normal on chest x-ray. The inspired oxygen concentration was raised to 100% and ventilation pressure to 30 cmH2O with 4 cmH2O end-expiratory pressure. Fig. 1 shows that despite these changes, the Pao2 could not be raised above 6 7 kPa (50 mmHg) until 6 hours after birth. At 10 hours, right radial and umbilical artery blood-gas tensions were identical (Fig. 1) Twin girls were delivered by caesarean section at 30 weeks' gestation to a 20-year-old mother after a pregnancy complicated by vaginal bleeding and preterm labour. 30 hours before delivery naproxen 250 mg 8 hourly had been begun. A total of 1 g was given, the last dose 5 hours before delivery.
The first twin weighed 1 18 kg. The Apgar score was 1 and positive pressure ventilation was given immediately. At 30 minutes while breathing 80% oxygen arterial pH was 7 -05, Pao2 6-7 kPa (51 mmHg), and Paco2 10-8 kPa (81 mmHg). The lung fields were clear and the heart size normal on chest x-ray. Haematocrit and blood glucose concentration were normal and the lecithin/sphingomyelin ratio (L/S) was 2-0 in the pharyngeal aspirate. The hypercarbia was rapidly corrected by artificial ventilation but Pao2 remained low despite pressures up to 35 cmH2O and 100% oxygen. Simultaneous right radial and umbilical blood-gas tensions taken when the baby was unresponsive were identical at 40 hours (Fig. 1) . Tolazoline hydrochloride (2 mg/kg, TV) produced an immediate improvement in oxygenation (Fig. 1 ventilation was necessary for 5 days after which chronic lung disease with oxygen dependency persisted for 12 weeks. During the first 2 days plasma bilirubin rose to 225 ,umol/l (13 -2 mg/100 ml) and bleeding time, prothrombin time, and partial thromboplastin time were prolonged. Urine volume was markedly reduced until the third day.
The second twin was delivered 2 minutes later and weighed 1 *26 kg. The Apgar score was 1 and severe hypoxaemia rapidly developed. Treatment and investigations were similar to those in the first twin. The L/S ratio was 3 -1, and within the first 24 hours the bilirubin rose to 230 ,umol/l (13.5 mg/100 ml).
Bleeding from the umbilical stump and heel punctures was prolonged and the clotting studies were abnormal. At 3 hours an intracranial haemorrhage was suspected. At 10 hours tolazoline hydrochloride (2 mg/kg, IV) rapidly improved oxygenation ( Fig. 1 ) and during the next 60 hours ventilatory assistance was gradually withdrawn. However, at 80 hours she suddenly became apnoeic with a distended abdomen and poor peripheral perfusion. Cardiac arrest occurred and resuscitation was unsuccessful. Necropsy showed a subarachnoid haemorrhage and blood in both ventricles. Multiple gastric ulcers were present and there was blood throughout the intestine. The ductus arteriosus was short and constricted and hyaline membranes were not seen in sections of the lungs. PGF), and 13, 14-dihydro-15-keto-PGF (PGFM) (the major circulating metabolite of PGF), were measured by methods described previously and in Fig. 2 the values at 10, 40, and 10 hours age are compared with the levels found in preterm infants of the same age who were not ill (Mitchell et al., 1978) . Discussion Persistent pulmonary hypertension presents during the first hours oflife with arterial oxygen desaturation in the absence of parenchymal pulmonary disease or cardiac malformation. The mechanisms responsible are not known but an altered structure or abnormal response of the smooth muscle of the pulmonary arterioles has been suggested (Levin et al., 1978) . The condition has been associated with birth asphyxia, hypoglycaemia, hypocalcaemia, and hyperviscosity. The 2 infants who survived (Cases 1 and 2) were not hypoxaemic at birth. Umbilical cord vein Po, was 4*1 and 2 9 kPa (31 and 22 mmHg). In Case 3 the umbilical cord was so friable that blood could not be obtained. Undoubtedly hypoxaemia after birth contributed to maintaining the high pulmonary vascular resistance. Cassin et al. (1978) showed that this effect of hypoxia is potentiated by indomethacin and meclofenamate (another PGSI). In their experiments with goats the response to indomethacin was more pronounced in the premature than mature newborn. They also reported than an infusion of PGE abolishes the response to hypoxia and can reverse the effect of the PGSI.
Constriction of the ductus arteriosus and pulmonary arterial hypertension after maternal indomethacin administration in fetal lambs has been reported by Levin et aL (1979) . This effect was also reversed promptly but temporarily by an infusion of PGE. In the 3 infants described here the identical gas tensions in blood drawn simultaneously from both sides of the ductus arteriosus ( Fig. 1) and the absence of a ductal flow murmur suggests that the ductus arteriosus had constricted. The very low concentrations of prostaglandin E in all 3 babies (Fig. 2) supports the view that this prostaglandin plays an important role in maintaining relaxation of the ductus arteriosus in utero and that constriction may follow inhibition ofprostaglandin synthesis.
The association between pulmonary hypertension and inhibition of prostaglandin synthesis in humans was first suggested by Manchester et aL (1976) who described 2 cases after treatment with indomethacin, and the report by Zuckerman et al. (1974) included 5 infants who died within 48 hours. Csaba et al. (1978) reported 2 deaths in 5 infants after indomethacin and Levin et al. (1978) reported 2 deaths, one each after salicylate and indomethacin treatment, in which they found an increase in pulmonary arterial smooth muscle and a decrease in the number of pulmonary vessels. This report is the first to implicate naproxen in a similar role.
When the severe hypoxaemia of the twins (Cases 2 and 3) was refractory to other treatment we gave tolazoline hydrochloride which caused a large rise in Pao2 (Fig. 1 ). There was a pronounced skin flush and fall in systolic blood pressure from 58 to 35 mmHg and 69 to 39 mmHg which was restored immediately by infusing albumin and blood. Tolazoline is a potent pulmonary and systemic vasodilator and blood pressure must be continuously monitored to detect severe hypotension. The gastric ulceration and bleeding found at necropsy (Case 3) was probably due to the histaminic action of tolazoline on gastric secretion. It is less certain whether the cerebral bleeding preceded the infusion of tolazoline or not.
The role of naproxen in the aetiology of early hyperbilirubinaemia, the abnormalities in blood clotting, and the impairment of renal function remain to be defined.
There is no universally effective and safe way of delaying preterm labour, and only when details of all the effects of PGSI are known will it be possible to decide whether there is any benefit to the fetus from this form of treatment. At present the possible hazards outweigh the theoretical advantage taking into account the improved prognosis for premature infants with current management. 
